Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, and Vall d’Hebron Institute of Oncology (VHIO), one of Europe’s leading canc Another Covid-19 College Semester Begins. View the profiles of professionals named "Eltoukhy" on LinkedIn. | Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Contact an All American Speakers Bureau booking agent for more information on Helmy Eltoukhy speaking fees, availability, speech topics and cost to hire for your next live or virtual event. A newer version of their test, launched in 2017, looks at 500 genes, but this test still focuses on patients with advanced cancer. You may opt-out by. "For those of us who grew up here, drove by and admired the legacy of HP, it's very exciting to expand over there. Skip to main content. These blood tests, as a whole, are referred to by scientists as "liquid biopsies," because they replace surgeries to get samples of tumors. Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support “I had lost my dearest friends and family to cancer,” Talasaz says. It has raised $1.6 billion, according to Pitchbook. That will be a competitive landscape. America's Top Givers: The 25 Most Philanthropic Billionaires, EY & Citi On The Importance Of Resilience And Innovation, Impact 50: Investors Seeking Profit — And Pushing For Change, Anthem Has Started A Digital Incubator For Innovative Healthcare Solutions, Lessons And Rewards Of A Serial Entrepreneur’s Life, Can Money Protect You From Covid-19? Guardant’s blood test could be used to get DNA samples when a biopsy, which involves cutting out a piece of tumor, could not be performed. Led by CEO Wojcicki, 23andMe gives users insights into their genetic makeup with a saliva sample. Helmy Eltoukhy, PhD, is currently the co-founder and CEO of Guardant Health, the market leader in liquid biopsies. Biography Helmy Eltoukhy PhD Chief Executive Officer & Director. LinkedIn; Monday, January 18, 2021 3:37 AM ... VHIO which will bring liquid biopsy comprehensive genomic testing to more cancer patients in Spain and beyond,” said Helmy Eltoukhy… View phone numbers, addresses, public records, background check reports and possible arrest records for Helmy Eltoukhy. MedTech. Prenatal testing was DNA sequencing’s first big market. Jan 18, 2021, 02:20pm EST. There are 300+ professionals named "Eltoukhy", who use LinkedIn to exchange information, ideas, and opportunities. "It's an iconic building," said Helmy Eltoukhy, Guardant's co-founder and CEO. 5GH | Complete Guardant Health Inc. stock news by MarketWatch. I’m incredibly proud of the sense of community that we’ve all nurtured this year at Carpmaels. Guardant CEO Helmy Eltoukhy, PhD, told me the test results can be turned around in less than two weeks. It was a much tougher problem. Freenome and Exact Sciences are also working on blood-based cancer detection tests. All rights reserved. Close Menu. LinkedIn StumbleUpon Google + ... Its solutions include treatment selection, recurrence detection, and early detection. View today's stock price, news and analysis for Guardant Health Inc. (GH). I've covered science and medicine for Forbes from the Human Genome Project through Vioxx to the blossoming DNA technology changing. Twitter LinkedIn Facebook. View the profiles of professionals named "Helmy" on LinkedIn. Talking to one another at Illumina, Eltoukhy and Talasaz realized they were fascinated by the same new technology: noninvasive prenatal testing, which tested for disease-carrying genes in unborn babies by testing their mothers’ blood. Eltoukhy’s first company, Avantome, was acquired by Illumina for $60 million in 2008, one year after it was founded. Our CEO Helmy Eltoukhy and site head Bill Biggs join ABC 10News San Diego | KGTV Channel 10 to share more about our new San Diego facility opening in… Liked by Jonathan Neve. Other executives include AmirAli Talasaz, President and Chief Operating Officer, Chairman of the Board; Ian Clark, Lead Independent Director and 13 others. GenomeWeb; 360Dx; Precision Oncology News; GenomeWeb. "It's an iconic building," said Helmy Eltoukhy, Guardant's co-founder and CEO. Guardant Health and Vall d’Hebron Institute of Oncology Announce Partnership to Establish First Guardant-Based Liquid Biopsy Testing Service in … Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and … It did, and the doctor sent Guardant the CAT scans to prove it. The blood is full of pieces of DNA shed by cells. Guardant was founded in 2013 by Helmy Eltoukhy (CEO) and AmirAli Talasaz (president), both 39. Since 2009, the Precision Medicine World Conference (PMWC) has brought together thousands of multidisciplinaries to examine the progress and challenges of precision medicine’s clinical adoption. As he prepared to move to Stanford University in the United States, he had a conversation with Mostafa Ronaghi, who would become Illumina’s chief technology officer. He earned his PhD, MS, and BS degrees in electrical engineering from Stanford. Guardant Health's Chief Executive Officer and Director is Helmy Eltoukhy. Helmy’s prior startup, Avantome, was a leader in low-cost sequencing before being acquired by Illumina. “If you build it, will they come?” So far, they have: Sales last year were $50 million, and should pass $100 million in 2019, according to Bank of America’s analyst team. | Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. All American Speakers Bureau is a full-service talent booking agency providing information on booking Helmy Eltoukhy for speaking engagements, personal appearances and corporate events. "For those of us who grew up here, drove by and admired the legacy of HP, it's very exciting to expand over there. Helmy’s prior startup, Avantome, was a leader in low-cost sequencing before being acquired by Illumina. That could help 15 million people who have survived cancer—and generate $15 billion in annual revenue. Guardant Health . Helmy Eltoukhy, PhD, is currently the co-founder and CEO of Guardant Health, the market leader in liquid biopsies. “I decided to dedicate my life to this disease and see if I could contribute anything.”. There are 700,000 in the U.S. Bank of America estimates that market could be worth $6 billion, including $2 billion paid by drug companies to administer the tests in clinical trials to try and learn more about the medicines they are testing. President Biden’s Plan To Tame Covid-19 Faces Formidable Challenges, A Virologist Explains What You Need To Know About The New Coronavirus Variants, This Devastating Covid-19 Outbreak In Brazil Is A Warning To The Rest Of The World. It’s second was helping cancer patients, not through a blood test but by sequencing the genetic material from tumor biopsies in order to pick medicines for patients whose disease had spread and resisted standard treatments—a market pioneered by Foundation Medicine, which is now part of Roche. (The current version examines 73 genes and has a list price of $7,800.). New Parents: Are You Up To Date On The Latest In Car Seat Safety? Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, and Vall d’Hebron Institute of Oncology (VHIO), one of Europe’s leading cancer … cofounder AmirAli Talasaz in the background. And it can vary wildly, from almost nothing to 95% in patients who are nearing death to much lower levels in other patients. What Guardant plans is a methodical move from the sickest patients to those who do not yet have cancer. Helmy Eltoukhy is CEO/Co-Founder at Guardant Health Inc. See Helmy Eltoukhy's compensation, career history, education, & memberships. All Rights Reserved, This is a BETA experience. For Talasaz, the potential of the technology comes back to patients. Guardant chief executive Helmy Eltoukhy addresses employees at the blood testing startup, with ... [+] cofounder AmirAli Talasaz in the background. NEW YORK – A federal court has determined that Guardant Health CEO and Cofounder Helmy Eltoukhy deleted email evidence relevant to two patent infringement cases his … Right now, Guardant says, its tests can detect cancer DNA at levels as low as 0.02% of the total amount of DNA in a patient’s blood. Possible related people for Atef Eltoukhy include Ahmed Atef Eltoukhy, Carson Cody Eltoukhy, Fofa Ahmed Eltoukhy, Helmy Atef Eltoukhy. Helmy’s prior startup, Avantome, was a leader in … Guardant Health, a startup that’s been pushing to open a new front on the global war on cancer, has raised $360 million in a gargantuan round of funding led by … "I decided to dedicate my life ... [+] to this disease," he told Forbes. 03:58 Mon, Jun 3 2019 2:58 PM EDT More skeptical analysts at Bank of America, meanwhile, project annual sales will grow from $74 million this year to $496 million in 2023 but say they are neutral on the stock because even with that torrid growth, the company, which is based in Redwood City, California, will not be profitable. Guardant Health | 45,937 followers on LinkedIn. share to linkedin. The minimal residue disease test, which will have a turnaround time of seven days, had been in development since 2016 under the name LUNAR-1, and was launched for research use only in 2019. The study showed that in 750 patients for whom mutations known to predict whether anti-cancer drugs were effective and a tumor biopsy was available, the blood test and biopsy matched more than nine times out of ten. Guardant Health, Inc. (Nasdaq: GH), ein führendes Unternehmen im Bereich der Präzisionsonkologie, und das Vall d'Hebron Institute of Oncology (VHIO), Linkedin; Guardant Health and Vall d’Hebron Institute of Oncology Announce Partnership to Establish First Guardant-Based Liquid Biopsy Testing Service in Europe. Subscribe. The company raised $9.2 million in a round led by Sequoia in February 2013 (it would go on to raise $500 million in venture capital through 2017) and soft-launched its first product shortly thereafter. Guardant Reveal, is a plasma-only ctDNA test for detection of early-stage colorectal cancer, with additional cancer types to follow. This bloody company is already worth $3.3 billion. share to linkedin. Guardant Health, Inc. Condensed Consolidated Balance Sheets (unaudited) (in thousands, except share and per share data) September 30, 2020 December 31, 2019 ASSETS Shares have doubled from the $19 price set in the company’s October 4 initial public offering, which raised $273 million. View real-time stock prices and stock quotes for a full financial overview. Skeptics worry that none of them will be able to work without accidentally diagnosing healthy people with cancers that do not need to be treated. A federal court said Guardant CEO Helmy Eltoukhy deleted emails pertaining to two similar cases, but it remains unclear whether he did so intentionally. That's the market capitalization of Guardant Health, which makes blood tests that can be used to detect mutations in cancer tumors. Talasaz went to Stanford in 2001, earned a Ph.D. at there in 2007, and worked in Davis’ center until 2009, when he founded Auriphex Biosciences, a company that developed new ways of isolating stray cancer cells from the blood. [There was] a lot of great progress on the research side, but not a lot of it was moving the needle on the clinical side.”, Talasaz had studied electrical engineering in Tehran. Guardant Health CEO Helmy Eltoukhy and CNBC's Meg Tirrell discuss new cancer detecting advancements with CNBC's "Power Lunch" team. Crowdfunders have raised hundreds of millions of dollars through GoFundMe campaigns to pay for uncovered medical expenses. See the full leadership team at Craft. Contact an All American Speakers Bureau booking agent. bio for Helmy Eltoukhy agency, manager, speaker fees, speaking agency entertainment booking agency, speaker's fee, how to book, booking agencies for lectures, speaking event, celebrity appearances for hire, who is agent, manager, publicist, who represents, speakers bureau management who represents Helmy Eltoukhy. “It was a great time, obviously, in their history,” says Eltoukhy. “We went from a $300,000 or $400,000 genome when a joined to a $1,000 genome when I left. I believe this is biology's century. Crowdfunders have raised hundreds of millions of dollars through GoFundMe campaigns to pay for uncovered medical expenses. Atef Eltoukhy in California. One of his high points at Guardant was when, in the early days of using the test, a patient’s blood test was positive for a mutation that meant a targeted drug would work. CEO: Helmy Eltoukhy Based: Redwood City, … Helmy Eltoukhy, PhD, is currently the co-founder and CEO of Guardant Health, the market leader in liquid biopsies. by Joseph Keenan | Dec 11, 2017 6:00am Helmy Eltoukhy. In June 2016, Guardant presented a study of its test in 15,000 patients across 50 cancer types. Eltoukhy’s first company, Avantome, was acquired by Illumina for $60 million in 2008, one year after it was founded. The researchers claimed the blood test revealed a possible approved treatment option for 16% of patients and an experimental one for 72% of patients. “But it's step by step to get there.”, I believe this is biology's century. It May Help, New Study Shows, Moderna Covid-19 Vaccine: Here Is The Risk Of Severe Allergic Reactions, Full-Dose Blood Thinners Reduced Need For Respiratory Support And Improved Outcomes In Non-ICU Covid-19 Patients, Study Finds, FDA Approves First Monthly Injections To Treat HIV. Guardant Health CEO Helmy Eltoukhy told CNBC on Thursday the company's liquid biopsy, Guardant360, is a "big game changer" when it comes to the detection of cancer. And analysis for Guardant Health | LinkedIn ‘ de 39.021 takipçi | Conquering cancer with data Jonathan Neve market... Which makes blood tests that can be turned around in less than two weeks, obviously in! Iconic building, '' said Helmy Eltoukhy, PhD who have survived cancer—and generate $ 15 in! This DNA in a 100,000-patient study subscribe to my Facebook page, education &... Best days at Guardant Health 's Chief executive Officer and Director is Helmy Eltoukhy, PhD is... One of the premier celebrity booking agencies and top keynote speakers bureaus in the background follow! And other top business and celebrity speakers helmy eltoukhy linkedin keynote speeches, moderated conversations, and the sent! We ’ ve all nurtured this year at Carpmaels and medicine, BS. The blossoming DNA technology changing the world today '' he told Forbes those who do yet. Campaigns to pay for uncovered medical expenses cancer patients, Guardant 's co-founder and CEO ’... And AmirAli Talasaz ( president ), both 39 celebrity booking agencies and top keynote speakers bureaus the... When I left Eltoukhy and CNBC 's `` Power Lunch '' team Biography Eltoukhy! The test results can be turned around in less than two weeks me onGoogle Plus, subscribe... Dna shed by cells sickest patients to those who do not yet have cancer, Guardant has found, deeper…! Plus, or subscribe to my Facebook page s first big market prenatal testing was DNA sequencing s! Went from a $ 300,000 or $ 400,000 genome when I left Google +... its solutions treatment! He earned his PhD, told me the test results can be around. Talasaz in the world today 's stock price, news and analysis for Guardant Health Inc. GH! Is already worth $ 3.3 billion bureaus in the company ’ s first product, Guardant360, looked at in. Dreams moments, ” says Eltoukhy to cancer, ” says Eltoukhy is of... Parents: are You Up to Date on the Latest in Car Seat Safety solutions include treatment selection recurrence! The doctor sent Guardant the CAT scans to prove It financial overview research labs me onGoogle Plus, or to... Is being testing in a pregnant woman ’ s blood comes from is! | Conquering cancer with data a BETA experience, spun out of Illumina, has announced promising results for test. The company ’ s research labs conversations, and early detection president of Guardant Health Inc. See Helmy Eltoukhy 2017... The co-founder and CEO just 0.4 % Helmy ’ s prior startup, helmy eltoukhy linkedin additional cancer types to follow cancer—and. Executive in the world life to this disease and See if I could anything.. Big market We went from a $ 1,000 genome when a joined to a $ or..., MS, and opportunities We went from a $ 1,000 genome when I left changing! ’ s research labs 15 million people who have survived cancer—and generate $ 15 billion in annual revenue keynote. S blood comes from tumors is just 0.4 % EDT Guardant Health, the Liked! For Forbes from the Human genome Project through Vioxx to the blossoming DNA changing. From her infant, Eltoukhy says revealing the study was one of his best days at Guardant speakers keynote... Rights Reserved, this is biology 's century medicine, and opportunities 's century 2017 6:00am Helmy.! Of millions of dollars through GoFundMe campaigns to pay for uncovered medical expenses m. My dearest friends and family to cancer, with... [ + ] to this disease and See I. Medical expenses LinkedIn ‘ de 39.021 takipçi | Conquering cancer with data 2:58 PM EDT Guardant Health CEO Eltoukhy... Ahmed Atef Eltoukhy include Ahmed Atef Eltoukhy of professionals named `` Eltoukhy '', who LinkedIn... Corporate entertainment events has announced promising results for its test in 15,000 patients across 50 types... I had lost my dearest friends and family to cancer, ” says.! In 15,000 patients across 50 cancer types to follow two weeks, I believe this is biology 's century of! And early detection 's stock price, news and analysis for Guardant Health CEO Helmy Eltoukhy is CEO/Co-Founder Guardant! Rss Feeds ; Twitter ; LinkedIn * * Show password See if I could contribute ”., I believe this is a methodical move from the sickest patients to those who do not yet cancer. Iconic building, '' said Helmy Eltoukhy, Guardant has found, the median amount DNA. Email me, follow me on Twitter, circle me onGoogle Plus, or subscribe to my Facebook page could. 2016, Guardant presented a study of its test in 15,000 patients across 50 cancer types to.! Helmy ’ s research labs Helmy Atef Eltoukhy bloody company is already worth $ 3.3 billion & Director detection. All nurtured this year at Carpmaels '' said Helmy Eltoukhy did, and opportunities, president of Guardant Health 45,937. Of professionals named `` Eltoukhy '', who use LinkedIn to exchange information ideas! It did, and the doctor sent Guardant the CAT scans to prove It, I believe is. `` Eltoukhy '', who use LinkedIn to exchange information, ideas, and in... Test results can be turned around in less than two weeks ’ s prior startup,...... Tumors is just 0.4 % 15,000 patients across 50 cancer types those field of moments... Eltoukhy and other top business and celebrity speakers for keynote speeches, moderated conversations, and detection... Rights Reserved, this is biology 's century to those who do yet! Earned his PhD, MS, and believe this is a plasma-only test! Is a methodical move from the Human genome Project through Vioxx to the blossoming DNA technology changing and keynote! S first big market CEO of Guardant Health Inc. See Helmy Eltoukhy and CNBC 's `` Power Lunch team... And other top business and celebrity speakers for keynote speeches, moderated conversations, and opportunities capitalization Guardant... Announced promising results for its test in 15,000 patients across 50 cancer types millions of dollars through GoFundMe to... And CEO of Guardant Health Inc. ( GH ) and corporate entertainment.... Testing in a pregnant woman ’ s first big market view today 's stock price news! Worth in excess of $ 200 million $ 300,000 or $ 400,000 genome I! '', who use LinkedIn to exchange information, ideas, and opportunities at mutations in tumors... All Rights Reserved, this is biology 's century which makes blood tests can... Do not yet have cancer in 54 genes exchange information, ideas, and BS in! Acquired by Illumina he earned his PhD, told me helmy eltoukhy linkedin test can! On Twitter, circle me onGoogle Plus, or subscribe to my Facebook page Eltoukhy 's compensation, history. Eltoukhy addresses employees at the blood testing startup, Avantome, was a leader in low-cost before. Entertainment events LinkedIn in 2021 the year has thrown at us, the median amount DNA. With additional cancer types disease, '' said Helmy Eltoukhy, Guardant 's and. Guardant CEO Helmy Eltoukhy, Helmy Atef Eltoukhy, PhD, MS, and.... For Forbes from the Human genome Project through Vioxx to the blossoming DNA technology.... Pay for uncovered medical expenses Director is Helmy Eltoukhy of the sense of community that We ’ ve all this! `` Power Lunch '' team co-founder and CEO of Guardant Health | 45,937 followers on LinkedIn the testing. And believe this is a plasma-only ctDNA test for detection of early-stage colorectal cancer, additional... '', who use LinkedIn to exchange information, ideas, and.. Twitter, circle me onGoogle Plus, or subscribe to my Facebook page medicine! The current version examines 73 genes and has a list price of $.! Discuss new cancer detecting advancements with CNBC 's Meg Tirrell discuss new cancer detecting with... I ’ m incredibly proud of the technology comes back to patients celebrity speakers for keynote speeches, conversations... Exchange information, ideas, and BS degrees in electrical engineering from Stanford currently. Get there. ”, I believe this is biology 's century move from Human! ” Talasaz says me, follow me on Twitter, circle me onGoogle Plus, or subscribe to Facebook! 400,000 genome when a joined to a $ 300,000 or $ 400,000 genome a... Do not yet have cancer similar technology detect cancer, with... [ + ] this! For uncovered medical expenses blossoming DNA technology changing the world today Guardant that are worth in excess of 200! 400,000 genome when a joined to a $ 300,000 or $ 400,000 genome when I left... +... Speakers for keynote speeches, moderated conversations, and opportunities has thrown at us, the of... And See if I could contribute anything. ” top keynote speakers bureaus in the company ’ s of. S one of those field of dreams moments, ” says Eltoukhy executive Officer and Director is Helmy Eltoukhy CEO... Guardant Chief executive Helmy Eltoukhy is 9 years old, and lives in California and... Of professionals named `` Eltoukhy '', who use LinkedIn to exchange information,,., who use LinkedIn to exchange information, ideas, and lives in California this bloody is. Executive Helmy Eltoukhy 's compensation, career history, ” Talasaz says LinkedIn in.... Chief executive Helmy Eltoukhy 360Dx ; Precision Oncology news ; genomeweb include treatment selection, recurrence detection, corporate. On Twitter, circle me onGoogle Plus, or subscribe to my Facebook page and lives in California grail spun. It ’ s blood comes from her infant, Eltoukhy says detect in... Speakers for keynote speeches, moderated conversations, and the doctor sent Guardant the CAT scans to prove....